Sponsor:
Cardurion Pharmaceuticals, Inc.
Code:
NCT06215586
Conditions
Heart Failure
Heart Failure Preserved Ejection Fraction
Cardiovascular Diseases
Heart Diseases
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tovinontrine (CRD-750
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-12. This information was provided to ClinicalTrials.gov by Cardurion Pharmaceuticals, Inc. on 2025-05-23.